Cargando…

Irritable Bowel Syndrome in Iran: SEPAHAN Systematic Review No. 1

OBJECTIVES: Irritable bowel syndrome (IBS) is a common gastrointestinal disorder. Due to its high prevalence and absence of curative therapy, IBS has the potential to create tremendous burden on the health care system. Herein, we systematically reviewed the published literature to investigate the ep...

Descripción completa

Detalles Bibliográficos
Autores principales: Jahangiri, Pegah, Jazi, Marsa Sadat Hashemi, Keshteli, Ammar Hassanzadeh, Sadeghpour, Shirin, Amini, Ehssan, Adibi, Peyman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399304/
https://www.ncbi.nlm.nih.gov/pubmed/22826748
_version_ 1782238387745325056
author Jahangiri, Pegah
Jazi, Marsa Sadat Hashemi
Keshteli, Ammar Hassanzadeh
Sadeghpour, Shirin
Amini, Ehssan
Adibi, Peyman
author_facet Jahangiri, Pegah
Jazi, Marsa Sadat Hashemi
Keshteli, Ammar Hassanzadeh
Sadeghpour, Shirin
Amini, Ehssan
Adibi, Peyman
author_sort Jahangiri, Pegah
collection PubMed
description OBJECTIVES: Irritable bowel syndrome (IBS) is a common gastrointestinal disorder. Due to its high prevalence and absence of curative therapy, IBS has the potential to create tremendous burden on the health care system. Herein, we systematically reviewed the published literature to investigate the epidemiology of IBS in Iran. METHODS: Studies that were reviewed in this article were primarily identified through four online bibliographic databases including PubMed, Google Scholar, Iran Medex, and Scientific Information Database. Manual search of reference lists was carried out to identify any additional studies such as relevant abstracts and also recent review articles which may have been missed. Potentially related studies were retrieved and the selection criteria were applied. Eligible articles were reviewed. RESULTS: From 4176 studies identified, 18 eligible studies were included. It was reported that in Iran, the prevalence of IBS was in the range of 1.1% to 25% and was more common in women. In addition, the difference in frequency of different age groups was minimal. There was a minimal difference in IBS prevalence within different age groups. CONCLUSIONS: In Iran, the incidence of IBS was in the wide range. Since there are not enough population-based studies, researchers should focus on developing well-designed population-based studies to determine the epidemiology of IBS in Iran. Moreover, cohort studies should be conducted in order to investigate the natural history of IBS. Investigating the etiology of IBS and attempt to organize health promotion programs are highly suggested.
format Online
Article
Text
id pubmed-3399304
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-33993042012-07-23 Irritable Bowel Syndrome in Iran: SEPAHAN Systematic Review No. 1 Jahangiri, Pegah Jazi, Marsa Sadat Hashemi Keshteli, Ammar Hassanzadeh Sadeghpour, Shirin Amini, Ehssan Adibi, Peyman Int J Prev Med Review Article OBJECTIVES: Irritable bowel syndrome (IBS) is a common gastrointestinal disorder. Due to its high prevalence and absence of curative therapy, IBS has the potential to create tremendous burden on the health care system. Herein, we systematically reviewed the published literature to investigate the epidemiology of IBS in Iran. METHODS: Studies that were reviewed in this article were primarily identified through four online bibliographic databases including PubMed, Google Scholar, Iran Medex, and Scientific Information Database. Manual search of reference lists was carried out to identify any additional studies such as relevant abstracts and also recent review articles which may have been missed. Potentially related studies were retrieved and the selection criteria were applied. Eligible articles were reviewed. RESULTS: From 4176 studies identified, 18 eligible studies were included. It was reported that in Iran, the prevalence of IBS was in the range of 1.1% to 25% and was more common in women. In addition, the difference in frequency of different age groups was minimal. There was a minimal difference in IBS prevalence within different age groups. CONCLUSIONS: In Iran, the incidence of IBS was in the wide range. Since there are not enough population-based studies, researchers should focus on developing well-designed population-based studies to determine the epidemiology of IBS in Iran. Moreover, cohort studies should be conducted in order to investigate the natural history of IBS. Investigating the etiology of IBS and attempt to organize health promotion programs are highly suggested. Medknow Publications & Media Pvt Ltd 2012-03 /pmc/articles/PMC3399304/ /pubmed/22826748 Text en Copyright: © International Journal of Preventive Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Jahangiri, Pegah
Jazi, Marsa Sadat Hashemi
Keshteli, Ammar Hassanzadeh
Sadeghpour, Shirin
Amini, Ehssan
Adibi, Peyman
Irritable Bowel Syndrome in Iran: SEPAHAN Systematic Review No. 1
title Irritable Bowel Syndrome in Iran: SEPAHAN Systematic Review No. 1
title_full Irritable Bowel Syndrome in Iran: SEPAHAN Systematic Review No. 1
title_fullStr Irritable Bowel Syndrome in Iran: SEPAHAN Systematic Review No. 1
title_full_unstemmed Irritable Bowel Syndrome in Iran: SEPAHAN Systematic Review No. 1
title_short Irritable Bowel Syndrome in Iran: SEPAHAN Systematic Review No. 1
title_sort irritable bowel syndrome in iran: sepahan systematic review no. 1
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399304/
https://www.ncbi.nlm.nih.gov/pubmed/22826748
work_keys_str_mv AT jahangiripegah irritablebowelsyndromeiniransepahansystematicreviewno1
AT jazimarsasadathashemi irritablebowelsyndromeiniransepahansystematicreviewno1
AT keshteliammarhassanzadeh irritablebowelsyndromeiniransepahansystematicreviewno1
AT sadeghpourshirin irritablebowelsyndromeiniransepahansystematicreviewno1
AT aminiehssan irritablebowelsyndromeiniransepahansystematicreviewno1
AT adibipeyman irritablebowelsyndromeiniransepahansystematicreviewno1